Earlier this morning, International Stem Cell Corp. announced that it will be hosting a conference call later this week. Dr. Simon Craw, Executive Vice President of International Stem Cell, and Ms. Linh Nguyen, Chief Financial Officer, will be present to discuss ISCO’s financial results for the three months ended September 30, 2012.
Those who wish to attend the call should note the information below:
Date: Friday, November 9, 2012
Time: 11:00 a.m. Eastern Time
Conference Line (U.S.): 1-877-317-6776
International Dial-In: 1-412-317-6776
Conference ID: 10020806
Webcast: http://webcast.mzvaluemonitor.com/Home/Login/630
Investors are advised to dial in at least 10 minutes before the call. Those unable to attend at the scheduled time will be able to listen to the recording by dialing 1-877-344-7529 within the United States or 1-412-317-0088 when calling internationally. Please use the replay pin number 10020806.
ISCO specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
For more information, visit www.internationalstemcell.com
Let us hear your thoughts below: